These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

82 related items for PubMed ID: 8282076

  • 1. Strategies for modulating Trk receptor activity.
    Hempstead BL.
    Exp Neurol; 1993 Nov; 124(1):31-5. PubMed ID: 8282076
    [No Abstract] [Full Text] [Related]

  • 2. NGF induces terminal differentiation in trkA expressing neuroblastoma cells in vitro and in vivo.
    Matsushima H, Bogenmann E.
    Prog Clin Biol Res; 1994 Nov; 385():177-83. PubMed ID: 7972210
    [No Abstract] [Full Text] [Related]

  • 3. P53 associates with trk tyrosine kinase.
    Montano X.
    Oncogene; 1997 Jul 17; 15(3):245-56. PubMed ID: 9233759
    [Abstract] [Full Text] [Related]

  • 4. Nerve growth factor derived from terminals selectively increases the ratio of p75 to trkA NGF receptors on mature sympathetic neurons.
    Miller FD, Speelman A, Mathew TC, Fabian J, Chang E, Pozniak C, Toma JG.
    Dev Biol; 1994 Jan 17; 161(1):206-17. PubMed ID: 8293873
    [Abstract] [Full Text] [Related]

  • 5. Regulation of NGF responsiveness in human neuroblastoma.
    Bogenmann E, Peterson S, Maekawa K, Matsushima H.
    Oncogene; 1998 Nov 05; 17(18):2367-76. PubMed ID: 9811468
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Trophic effect of exogenous nerve growth factor on rat striatal cholinergic neurons: comparison between intraparenchymal and intraventricular administration.
    Venero JL, Hefti F, Knusel B.
    Mol Pharmacol; 1996 Feb 05; 49(2):303-10. PubMed ID: 8632763
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Oncogenic activation of the tyrosine kinase domain of the human trk proto-oncogene by fusion to a cell adhesion molecule.
    Albor A, Thraves PJ, Dritschilo A, Notario V.
    Oncogene; 1996 Oct 17; 13(8):1755-63. PubMed ID: 8895522
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Expression of TRK-T1 oncogene induces differentiation of PC12 cells.
    Greco A, Orlandi R, Mariani C, Miranda C, Borrello MG, Cattaneo A, Pagliardini S, Pierotti MA.
    Cell Growth Differ; 1993 Jul 17; 4(7):539-46. PubMed ID: 8398895
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Neurotrophins. I: Molecular features].
    Zazpe A, Del Río J.
    Rev Med Univ Navarra; 1997 Jul 17; 41(3):173-9. PubMed ID: 10420923
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.